130 related articles for article (PubMed ID: 35876095)
1. Comparison of the outcomes between early and late anti-tumor necrosis factor therapy in patients with enthesitis-related subcategory of juvenile idiopathic arthritis: a multi-center study in Southeast Asia.
Vilaiyuk S; Lerkvaleekul B; Jino J; Charuvanij S; Book YX; Arkachaisri T
Expert Opin Biol Ther; 2022 Oct; 22(10):1323-1332. PubMed ID: 35876095
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.
Horneff G; Foeldvari I; Minden K; Trauzeddel R; Kümmerle-Deschner JB; Tenbrock K; Ganser G; Huppertz HI
Arthritis Rheumatol; 2015 May; 67(8):2240-9. PubMed ID: 25891010
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA): does duration matter?
Teh KL; Das L; Book YX; Hoh SF; Gao X; Arkachaisri T
Clin Rheumatol; 2024 May; 43(5):1723-1733. PubMed ID: 38443603
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
Kimura Y; Schanberg LE; Tomlinson GA; Riordan ME; Dennos AC; Del Gaizo V; Murphy KL; Weiss PF; Natter MD; Feldman BM; Ringold S;
Arthritis Rheumatol; 2021 Oct; 73(10):1898-1909. PubMed ID: 34105312
[TBL] [Abstract][Full Text] [Related]
5. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
Swart JF; van Dijkhuizen EHP; Wulffraat NM; de Roock S
Ann Rheum Dis; 2018 Mar; 77(3):336-342. PubMed ID: 29138257
[TBL] [Abstract][Full Text] [Related]
6. Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial.
Foeldvari I; Constantin T; Vojinović J; Horneff G; Chasnyk V; Dehoorne J; Panaviene V; Sušić G; Stanevicha V; Kobusinska K; Zuber Z; Dobrzyniecka B; Nikishina I; Bader-Meunier B; Breda L; Doležalová P; Job-Deslandre C; Rumba-Rozenfelde I; Wulffraat N; Pedersen RD; Bukowski JF; Vlahos B; Martini A; Ruperto N;
Arthritis Res Ther; 2019 May; 21(1):125. PubMed ID: 31122296
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.
Horneff G; Burgos-Vargas R; Constantin T; Foeldvari I; Vojinovic J; Chasnyk VG; Dehoorne J; Panaviene V; Susic G; Stanevica V; Kobusinska K; Zuber Z; Mouy R; Rumba-Rozenfelde I; Breda L; Dolezalova P; Job-Deslandre C; Wulffraat N; Alvarez D; Zang C; Wajdula J; Woodworth D; Vlahos B; Martini A; Ruperto N;
Ann Rheum Dis; 2014 Jun; 73(6):1114-22. PubMed ID: 23696632
[TBL] [Abstract][Full Text] [Related]
8. Presentation of enthesitis-related arthritis and juvenile-onset spondyloarthritis: a cross-sectional study in a pediatric and adult clinic.
Lanças SHS; Furlan MZB; Fernandes TAP; Drumond SGL; Magalhães CS
Adv Rheumatol; 2024 May; 64(1):39. PubMed ID: 38720369
[TBL] [Abstract][Full Text] [Related]
9. Capturing the enthesitis related arthritis contemporary profile of Caucasian patients in the era of biologics.
Deligeorgakis D; Trachana M; Pratsidou-Gertsi P; Dimopoulou D; Haidich AB; Garyfallos A
Rheumatol Int; 2020 Jun; 40(6):941-949. PubMed ID: 32322980
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.
Weiss PF; Xiao R; Brandon TG; Pagnini I; Wright TB; Beukelman T; Morgan-DeWitt E; Feudtner C
J Rheumatol; 2018 Jan; 45(1):107-114. PubMed ID: 28916542
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a composite disease activity score for juvenile idiopathic arthritis.
Consolaro A; Ruperto N; Bazso A; Pistorio A; Magni-Manzoni S; Filocamo G; Malattia C; Viola S; Martini A; Ravelli A;
Arthritis Rheum; 2009 May; 61(5):658-66. PubMed ID: 19405003
[TBL] [Abstract][Full Text] [Related]
13. Secukinumab in the treatment for patients with juvenile enthesitis related arthritis non-responsive to anti-TNF treatment according the Juvenile Spondyloarthritis Disease Activity Index.
Baer J; Klotsche J; Foeldvari I
Clin Exp Rheumatol; 2022 Mar; 40(3):620-624. PubMed ID: 34128790
[TBL] [Abstract][Full Text] [Related]
14. Prospective validation of the Juvenile Spondyloarthritis Disease Activity Index in children with enthesitis-related arthritis.
Zanwar A; Phatak S; Aggarwal A
Rheumatology (Oxford); 2018 Dec; 57(12):2167-2171. PubMed ID: 30107576
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre.
Goirand M; Breton S; Chevallier F; Duong NP; Uettwiller F; Melki I; Mouy R; Wouters C; Bader-Meunier B; Job-Deslandre C; Quartier P
Pediatr Rheumatol Online J; 2018 Apr; 16(1):21. PubMed ID: 29609643
[TBL] [Abstract][Full Text] [Related]
16. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease.
Shih YJ; Yang YH; Lin CY; Chang CL; Chiang BL
Pediatr Rheumatol Online J; 2019 Aug; 17(1):58. PubMed ID: 31443722
[TBL] [Abstract][Full Text] [Related]
17. Determinants of disease activity change over time in Enthesitis related arthritis: effect of structured outcome monitoring and clinical decision support.
Tirelli F; Xiao R; Brandon TG; Burnham JM; Chang JC; Weiss PF
Pediatr Rheumatol Online J; 2020 Oct; 18(1):79. PubMed ID: 33059694
[TBL] [Abstract][Full Text] [Related]
18. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
Tse SM; Laxer RM; Babyn PS; Doria AS
J Rheumatol; 2006 Jun; 33(6):1186-8. PubMed ID: 16755667
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
Funk RS; Chan MA; Becker ML
Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the Disease Activity Score-28 and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis].
Capela RC; Corrente JE; Magalhães CS
Rev Bras Reumatol; 2015; 55(1):31-6. PubMed ID: 25440705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
